Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -14.54%1.66B | ---- | -34.45%1.94B | ---- | -52.42%2.95B | ---- | 99.16%6.21B | ---- | 21.45%3.12B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -25.33%-647.56M | ---- | -23.79%-516.7M | ---- | 1.61%-417.42M | ---- | -397.07%-424.23M | ---- | -1,952.57%-85.35M |
| Impairment and provisions: | ---- | -46.18%38.24M | ---- | 483.89%71.06M | ---- | -53.59%12.17M | ---- | 307.56%26.23M | ---- | -146.15%-12.64M |
| -Impairmen of inventory (reversal) | ---- | -70.64%17.96M | ---- | 595.89%61.18M | ---- | 1,122.67%8.79M | ---- | 105.63%719K | ---- | -156.74%-12.76M |
| -Impairment of trade receivables (reversal) | ---- | 105.18%20.28M | ---- | 878.88%9.88M | ---- | -116.57%-1.27M | ---- | 5,837.21%7.66M | ---- | -97.36%129K |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | -73.96%4.65M | ---- | --17.85M | ---- | ---- |
| Revaluation surplus: | ---- | -119.71%-8.51M | ---- | 289.55%43.17M | ---- | 83.00%-22.78M | ---- | -113.21%-133.95M | ---- | 46,605.09%1.01B |
| -Other fair value changes | ---- | -119.71%-8.51M | ---- | 289.55%43.17M | ---- | 83.00%-22.78M | ---- | -113.21%-133.95M | ---- | 46,605.09%1.01B |
| Asset sale loss (gain): | ---- | -21.46%59.16M | ---- | 271.96%75.33M | ---- | 15,972.22%20.25M | ---- | -98.32%126K | ---- | -46.22%7.48M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -21.46%59.16M | ---- | 271.96%75.33M | ---- | 15,972.22%20.25M | ---- | -98.32%126K | ---- | -46.22%7.48M |
| Depreciation and amortization: | ---- | 5.05%285.14M | ---- | 22.24%271.43M | ---- | 153.07%222.04M | ---- | 56.10%87.74M | ---- | 88.27%56.21M |
| -Amortization of intangible assets | ---- | 23.15%20.07M | ---- | 86.33%16.29M | ---- | 106.37%8.74M | ---- | 44.81%4.24M | ---- | 78.74%2.93M |
| Financial expense | ---- | 39.24%37.86M | ---- | -6.17%27.19M | ---- | 15.71%28.98M | ---- | 62.96%25.05M | ---- | -15.43%15.37M |
| Unrealized exchange loss (gain) | ---- | 44.31%-43.42M | ---- | 26.38%-77.96M | ---- | -332.27%-105.9M | ---- | 9.44%45.59M | ---- | 268.25%41.66M |
| Special items | ---- | -30.29%200.28M | ---- | -23.14%287.32M | ---- | 43.23%373.82M | ---- | -27.28%261M | ---- | 498.12%358.9M |
| Operating profit before the change of operating capital | ---- | -25.56%1.58B | ---- | -30.93%2.12B | ---- | -49.72%3.07B | ---- | 35.09%6.1B | ---- | 65.84%4.51B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -39.85%243.94M | ---- | 635.10%405.53M | ---- | -54.90%55.17M | ---- | -58.87%122.31M | ---- | 940.72%297.34M |
| Accounts receivable (increase)decrease | ---- | -159.00%-502.36M | ---- | 131.31%851.5M | ---- | -18.99%-2.72B | ---- | -40.45%-2.29B | ---- | -311.70%-1.63B |
| Accounts payable increase (decrease) | ---- | 526.36%591.68M | ---- | -86.60%94.46M | ---- | 37.77%704.83M | ---- | 17.10%511.6M | ---- | 222.64%436.89M |
| Special items for working capital changes | ---- | 214.00%157.87M | ---- | -6,332.04%-138.48M | ---- | -96.27%2.22M | ---- | 165.61%59.65M | ---- | -150.51%-90.91M |
| Cash from business operations | ---- | -37.92%2.07B | ---- | 200.62%3.33B | ---- | -75.41%1.11B | ---- | 27.65%4.5B | ---- | 35.42%3.53B |
| China income tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -12.43%-474.13M |
| Other taxs | ---- | -128.38%-314.03M | ---- | 78.45%-137.5M | ---- | 30.38%-637.98M | ---- | ---916.32M | ---- | ---- |
| Special items of business | 34.99%813.76M | ---- | -43.79%602.83M | ---- | 421.81%1.07B | ---- | -113.65%-333.26M | ---- | 121.52%2.44B | ---- |
| Net cash from operations | 34.99%813.76M | -45.09%1.75B | -43.79%602.83M | 579.54%3.19B | 421.81%1.07B | -86.91%469.86M | -113.65%-333.26M | 17.46%3.59B | 121.52%2.44B | 39.85%3.05B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -37.74%147.05M | 16.81%599.1M | 70.84%236.18M | 33.14%512.86M | -2.84%138.24M | 32.53%385.22M | 5.95%142.28M | 271.90%290.68M | 2,939.61%134.29M | 2,407.51%78.16M |
| Decrease in deposits (increase) | 355.65%4.75B | 115.59%984.67M | -60.61%1.04B | -460.79%-6.31B | -6.43%2.65B | 68.69%-1.13B | -3.49%2.83B | -269.22%-3.6B | --2.93B | -6,358.19%-974.02M |
| Sale of fixed assets | ---- | 16,278.65%85.17M | ---- | -89.48%520K | -91.78%328K | -91.45%4.94M | -80.45%3.99M | 6,911.27%57.84M | 9,263.76%20.41M | -98.61%825K |
| Purchase of fixed assets | -6.28%-428.14M | 24.51%-897.67M | 14.16%-402.86M | 28.13%-1.19B | 28.00%-469.31M | 15.52%-1.65B | -35.73%-651.85M | -477.38%-1.96B | -177.69%-480.25M | 25.58%-339.23M |
| Purchase of intangible assets | -1,947.35%-187.03M | -226.50%-138.09M | 38.18%-9.14M | -5.25%-42.3M | -30.54%-14.78M | -192.99%-40.18M | -395.40%-11.32M | -71.57%-13.72M | 54.27%-2.29M | 86.32%-7.99M |
| Recovery of cash from investments | --2.32B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | -899.67%-6.07B | -14,452.45%-2.53B | -13,392.77%-606.91M | 12.90%-17.38M | 53.68%-4.5M | 3.35%-19.96M | 99.86%-9.71M | -185.88%-20.65M | -4,151,078.79%-6.85B | 58.36%-7.22M |
| Other items in the investment business | -55.29%3.31M | -6.44%31.38M | 43.62%7.41M | 26.41%33.55M | -1.15%5.16M | 74.82%26.54M | 213.21%5.22M | 148.21%15.18M | 100.15%1.67M | 98.57%-31.48M |
| Net cash from investment operations | 101.55%539.97M | 73.42%-1.86B | -88.37%267.91M | -189.44%-7.02B | -0.23%2.3B | 53.61%-2.42B | 154.41%2.31B | -307.94%-5.23B | -2,423.32%-4.24B | -161.71%-1.28B |
| Net cash before financing | 55.47%1.35B | 97.08%-111.62M | -74.21%870.74M | -95.64%-3.82B | 70.88%3.38B | -19.35%-1.95B | 209.61%1.98B | -192.30%-1.64B | -293.04%-1.8B | 4.66%1.77B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -56.04%563.06M | 237.73%3.23B | --1.28B | -57.02%957.36M | ---- | -7.62%2.23B | --1.72B | --2.41B | ---- | ---- |
| Refund | ---1.57B | -265.84%-1.97B | ---- | ---538M | ---- | ---- | ---- | ---- | ---- | -7,853.60%-79.54M |
| Issuing shares | 19,302.37%73.73M | 27.41%28.6M | -65.70%380K | -31.92%22.45M | 2,602.44%1.11M | -99.12%32.97M | -100.00%41K | -49.36%3.75B | --3.74B | 1,932.83%7.4B |
| Interest paid - financing | 26.43%-13.62M | -39.24%-37.86M | -68.60%-18.51M | 6.17%-27.19M | 28.38%-10.98M | -15.71%-28.98M | -102.27%-15.33M | -62.96%-25.05M | 8.63%-7.58M | 15.43%-15.37M |
| Dividends paid - financing | -1.19%-279.32M | 23.16%-552.39M | 37.14%-276.04M | 50.35%-718.89M | 52.05%-439.16M | 38.91%-1.45B | 30.69%-915.9M | ---2.37B | ---1.32B | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | -1,172.28%-247.08M | -207.19%-161.79M | 87.02%-19.42M | -2,168.13%-52.67M | -7,207.33%-149.58M |
| Other items of the financing business | ---- | -350.11%-603.74M | ---603.74M | -65.17%-134.13M | ---- | 1.16%-81.21M | ---81.21M | ---82.16M | ---- | ---- |
| Net cash from financing operations | -491.09%-1.3B | 92.54%-45.71M | 161.73%332.13M | -321.72%-612.36M | -216.72%-537.99M | -92.16%276.19M | -79.91%460.94M | -50.09%3.52B | 3,996.49%2.29B | 471.51%7.06B |
| Effect of rate | -20,152.94%-13.77M | -189.49%-4.05M | -101.50%-68K | -67.89%4.53M | -63.17%4.54M | 187.22%14.1M | 222.46%12.33M | -189.94%-16.17M | -5.86%3.83M | 1.13%-5.58M |
| Net Cash | -95.44%54.83M | 96.45%-157.32M | -57.61%1.2B | -164.34%-4.44B | 16.47%2.84B | -189.01%-1.68B | 394.95%2.44B | -78.66%1.89B | -43.73%492.28M | 4,409.78%8.83B |
| Begining period cash | -3.03%5.17B | -45.38%5.33B | -45.38%5.33B | -14.56%9.76B | -14.56%9.76B | 19.55%11.43B | 19.55%11.43B | 1,206.79%9.56B | 1,206.79%9.56B | -22.35%731.39M |
| Cash at the end | -20.25%5.21B | -3.03%5.17B | -48.16%6.53B | -45.38%5.33B | -9.15%12.61B | -14.56%9.76B | 38.01%13.88B | 19.55%11.43B | 524.37%10.05B | 1,206.79%9.56B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.